EG reports earnings April 29 with positioning metrics showing competing signals across the derivatives and short-interest landscape. The stock closed Friday at $343.38, down 2.1% on the day but up 6.1% over the month. Short interest climbed 7.6% over the past week to 960,000 shares—2.3% of the float—while borrow costs remain negligible at 0.51%. Utilisation ticked up to 1.04%, well below the 52-week high of 3.39%, indicating plenty of available shares for those looking to bet against the reinsurer heading into the print.
Options positioning tells a different story. The put/call ratio dropped to 0.28, running 1.7 standard deviations below its 20-day mean of 0.68. That marks the most bullish options skew of the past year and suggests derivative traders are leaning into calls rather than hedging downside. The divergence is notable—short sellers are adding exposure at the fastest weekly pace in more than a month, yet options markets are positioned for upside.
Analyst activity has been mixed in the run-up. BofA lifted its target from $430 to $454 earlier this month while keeping a Buy rating, the most bullish call on the Street. Barclays raised to $380, and Mizuho nudged its Neutral-rated target to $365. Wells Fargo has been more cautious, cutting twice since early April and now sitting at $332—below the current price. Keefe Bruyette trimmed from $430 to $402 but held its Outperform rating. The consensus target of $372 implies 8% upside, though the range is wide. Bears point to persistent underperformance versus the S&P 500 and exposure to social inflation that could pressure reserves. Bulls see reaccelerating property rates and improving loss ratios as the 2025 tailwinds play out. The company trades at 6.2× trailing earnings and 0.78× book value, both sitting near multi-year lows on a relative basis.
Insider activity has been modest—net selling of roughly $4.3 million over 90 days, driven primarily by tax-related transactions tied to equity awards in mid-March. CEO James Williamson and CFO Mark Kociancic both sold shares at $322 and $338 around award vesting dates; the trades rank low on significance. Institutional holders remain stable, with Vanguard and BlackRock controlling nearly 20% of shares outstanding. Vulcan Value Partners added 92,000 shares in January, now holding 3.4% of the company. After the last three prints, the stock fell roughly 1% on the day but closed flat to slightly positive over the following five days—muted reactions that suggest the market has been pricing Everest efficiently around quarterly results.
The earnings call will test whether management's remediation strategies in the Insurance segment are translating into the expense-ratio relief the Street is looking for, and whether reserve adequacy holds up amid elevated social-inflation pressures. The derivatives setup suggests traders expect volatility to resolve higher; the short-interest build suggests some are willing to bet the other way.
See the live data behind this article on ORTEX.
Open EG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
